Stable silencing of Plexin-B1 impaired Sema4D-mediated activation of the RhoA and SRPK1 signaling in tumor cells, and resulted in a reduction of microvessel density in xenografts generated in vivo, due to an unknown mechanism [34]. The gene discussed is RHOA; the disease is neoplasm.